Jacobson Pharma Updates on TAILORx Study
- Written by ACN Newswire
Landmark TAILORx Results, Published in The New England Journal of Medicine, Demonstrate the Oncotype DX Breast Recurrence Score Test Definitively Identifies the 70% of Women with Early-stage Breast Cancer Who Receive No Benefit from Chemotherapy, and the 30% of Women for Whom Chemotherapy Benefit Can be Life-savingHONG KONG, Jun 13, 2018 - (ACN...